FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2800108839> ?p ?o ?g. }

• W2800108839 endingPage "H388" @default.
• W2800108839 startingPage "H375" @default.
• W2800108839 abstract "Apamin-sensitive small-conductance Ca2+-activated K+ (SK) current ( IKAS) is encoded by Ca2+-activated K+ channel subfamily N ( KCNN) genes. IKAS importantly contributes to cardiac repolarization in conditions associated with reduced repolarization reserve. To test the hypothesis that IKAS inhibition contributes to drug-induced long QT syndrome (diLQTS), we screened for KCNN variants among patients with diLQTS, determined the properties of heterologously expressed wild-type (WT) and variant KCNN channels, and determined if the 5-HT3 receptor antagonist ondansetron blocks IKAS. We searched 2,306,335 records in the Indiana Network for Patient Care and found 11 patients with diLQTS who had DNA available in the Indiana Biobank. DNA sequencing discovered a heterozygous KCNN2 variant (p.F503L) in a 52-yr-old woman presenting with corrected QT interval prolongation at baseline (473 ms) and further corrected QT interval lengthening (601 ms) after oral administration of ondansetron. That patient was also heterozygous for the p.S38G and p.P2835S variants of the QT-controlling genes KCNE1 and ankyrin 2, respectively. Patch-clamp experiments revealed that the p.F503L KCNN2 variant heterologously expressed in human embryonic kidney (HEK)-293 cells augmented Ca2+ sensitivity, increasing IKAS density. The fraction of total F503L-KCNN2 protein retained in the membrane was higher than that of WT KCNN2 protein. Ondansetron at nanomolar concentrations inhibited WT and p.F503L SK2 channels expressed in HEK-293 cells as well as native SK channels in ventricular cardiomyocytes. Ondansetron-induced IKAS inhibition was also demonstrated in Langendorff-perfused murine hearts. In conclusion, the heterozygous p.F503L KCNN2 variant increases Ca2+ sensitivity and IKAS density in transfected HEK-293 cells. Ondansetron at therapeutic (i.e., nanomolar) concentrations is a potent IKAS blocker. NEW & NOTEWORTHY We showed that ondansetron, a 5-HT3 receptor antagonist, blocks small-conductance Ca2+-activated K+ (SK) current. Ondansetron may be useful in controlling arrhythmias in which increased SK current is a likely contributor. However, its SK-blocking effects may also facilitate the development of drug-induced long QT syndrome." @default.
• W2800108839 created "2018-05-17" @default.
• W2800108839 creator A5004240247 @default.
• W2800108839 creator A5004272413 @default.
• W2800108839 creator A5004849126 @default.
• W2800108839 creator A5005569605 @default.
• W2800108839 creator A5006823579 @default.
• W2800108839 creator A5022448374 @default.
• W2800108839 creator A5028006741 @default.
• W2800108839 creator A5030241912 @default.
• W2800108839 creator A5031598463 @default.
• W2800108839 creator A5035463340 @default.
• W2800108839 creator A5035578414 @default.
• W2800108839 creator A5037520504 @default.
• W2800108839 creator A5048034644 @default.
• W2800108839 creator A5048900402 @default.
• W2800108839 creator A5059846691 @default.
• W2800108839 creator A5071194180 @default.
• W2800108839 creator A5081504895 @default.
• W2800108839 date "2018-08-01" @default.
• W2800108839 modified "2023-10-18" @default.
• W2800108839 title "Ondansetron blocks wild-type and p.F503L variant small-conductance Ca²⁺-activated K⁺ channels" @default.
• W2800108839 cites W1577822851 @default.
• W2800108839 cites W1861294888 @default.
• W2800108839 cites W1947741425 @default.
• W2800108839 cites W1968719390 @default.
• W2800108839 cites W1984685713 @default.
• W2800108839 cites W1997925229 @default.
• W2800108839 cites W2022501241 @default.
• W2800108839 cites W2024157977 @default.
• W2800108839 cites W2042998312 @default.
• W2800108839 cites W2059821011 @default.
• W2800108839 cites W2065229158 @default.
• W2800108839 cites W2071698136 @default.
• W2800108839 cites W2083337612 @default.
• W2800108839 cites W2087673585 @default.
• W2800108839 cites W2093869205 @default.
• W2800108839 cites W2118617344 @default.
• W2800108839 cites W2120471737 @default.
• W2800108839 cites W2125058889 @default.
• W2800108839 cites W2131308754 @default.
• W2800108839 cites W2145357374 @default.
• W2800108839 cites W2146629694 @default.
• W2800108839 cites W2151214424 @default.
• W2800108839 cites W2152124147 @default.
• W2800108839 cites W2160236062 @default.
• W2800108839 cites W2161163873 @default.
• W2800108839 cites W2181589980 @default.
• W2800108839 cites W2248460896 @default.
• W2800108839 cites W2286763607 @default.
• W2800108839 cites W2289199914 @default.
• W2800108839 cites W2346429157 @default.
• W2800108839 cites W2418519166 @default.
• W2800108839 cites W2523439891 @default.
• W2800108839 doi "https://doi.org/10.1152/ajpheart.00479.2017" @default.
• W2800108839 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6139629" @default.
• W2800108839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29677462" @default.
• W2800108839 hasPublicationYear "2018" @default.
• W2800108839 type Work @default.
• W2800108839 sameAs 2800108839 @default.
• W2800108839 citedByCount "18" @default.
• W2800108839 countsByYear W28001088392018 @default.
• W2800108839 countsByYear W28001088392019 @default.
• W2800108839 countsByYear W28001088392020 @default.
• W2800108839 countsByYear W28001088392021 @default.
• W2800108839 countsByYear W28001088392022 @default.
• W2800108839 countsByYear W28001088392023 @default.
• W2800108839 crossrefType "journal-article" @default.
• W2800108839 hasAuthorship W2800108839A5004240247 @default.
• W2800108839 hasAuthorship W2800108839A5004272413 @default.
• W2800108839 hasAuthorship W2800108839A5004849126 @default.
• W2800108839 hasAuthorship W2800108839A5005569605 @default.
• W2800108839 hasAuthorship W2800108839A5006823579 @default.
• W2800108839 hasAuthorship W2800108839A5022448374 @default.
• W2800108839 hasAuthorship W2800108839A5028006741 @default.
• W2800108839 hasAuthorship W2800108839A5030241912 @default.
• W2800108839 hasAuthorship W2800108839A5031598463 @default.
• W2800108839 hasAuthorship W2800108839A5035463340 @default.
• W2800108839 hasAuthorship W2800108839A5035578414 @default.
• W2800108839 hasAuthorship W2800108839A5037520504 @default.
• W2800108839 hasAuthorship W2800108839A5048034644 @default.
• W2800108839 hasAuthorship W2800108839A5048900402 @default.
• W2800108839 hasAuthorship W2800108839A5059846691 @default.
• W2800108839 hasAuthorship W2800108839A5071194180 @default.
• W2800108839 hasAuthorship W2800108839A5081504895 @default.
• W2800108839 hasBestOaLocation W28001088391 @default.
• W2800108839 hasConcept C118441451 @default.
• W2800108839 hasConcept C126322002 @default.
• W2800108839 hasConcept C134018914 @default.
• W2800108839 hasConcept C146403970 @default.
• W2800108839 hasConcept C149614440 @default.
• W2800108839 hasConcept C153911025 @default.
• W2800108839 hasConcept C170493617 @default.
• W2800108839 hasConcept C174510640 @default.
• W2800108839 hasConcept C185263204 @default.
• W2800108839 hasConcept C185592680 @default.
• W2800108839 hasConcept C2776919887 @default.
• W2800108839 hasConcept C2777170512 @default.

• next